Korea Investment Corp’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-89,531
Closed -$4.56M 707
2025
Q4
$4.56M Buy
89,531
+13,391
+18% +$685K 0.01% 601
2025
Q3
$4.23M Buy
76,140
+37,748
+98% +$2.21M 0.01% 601
2025
Q2
$2.65M Hold
38,392
0.01% 652
2025
Q1
$2.67M Buy
+38,392
New +$3.17M 0.01% 668

Other funds holding NVO

Korea Investment Corp's NVO Position: Q1 2026 in Review

Korea Investment Corp sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 89,531 shares — an estimated $4.56M sold.

Korea Investment Corp first reported a position in NVO in Q1 2025 and held it in 4 quarters. The position peaked at $4.56M in Q4 2025. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Korea Investment Corp reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Korea Investment Corp sold 89,531 Novo Nordisk shares in Q1 2026, an estimated $4.56M.
  • Korea Investment Corp first reported a position in Novo Nordisk in Q1 2025 and held it in 4 quarters.
  • Korea Investment Corp's Novo Nordisk position peaked at $4.56M in Q4 2025.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Korea Investment Corp's 13F filing for Q1 2026, filed 13 May 2026.